Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Filings indexed 987 across all filing types
Latest filing 2012-08-14 Director's Dealing
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2012-08-14 English
FORM 4
Director's Dealing
2012-08-14 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 13, 2012. It reports the entry into a material definitive agreement involving a private placement of common stock, amendments to the certificate of incorporation and bylaws, and related registration rights agreements. The content focuses on financing activities (private placement of shares), amendments to corporate governance documents, and related agreements. There are no financial statements or quarterly/annual financial results presented, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, earnings release, or AGM materials. The primary focus is on the financing transaction and related corporate changes. Therefore, the document fits best under Capital/Financing Update (CAP). The document length (9218 characters) and detailed description of the private placement and registration rights support this classification with high confidence.
2012-08-14 English
Regulatory Filings 2012
Regulatory Filings
2012-08-03 English
Regulatory Filings 2012
Regulatory Filings
2012-07-20 English
Regulatory Filings 2012
Regulatory Filings
2012-07-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.